These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 38783431

  • 21. Association of urinary albumin excretion with insulin resistance in Japanese subjects: impact of gender difference on insulin resistance.
    Utsunomiya K, Takamatsu K, Fukuta I, Sakamoto H, Ishizawa S, Kanazawa Y, Gojo A, Taniguchi K, Yokota T, Kurata H, Nomura K, Tajima N.
    Intern Med; 2009; 48(18):1621-7. PubMed ID: 19755764
    [Abstract] [Full Text] [Related]

  • 22. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
    Zhai Y, Cao X, Liu S, Shen Y.
    Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S, Singh VP, Agarwal AK, Chatterjee S, Araya V.
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA, Hassanien MA, Ibrahim EA, El-Noeman Sel-D.
    J Diabetes Complications; 2010 Nov; 24(5):325-33. PubMed ID: 19553142
    [Abstract] [Full Text] [Related]

  • 31. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
    Shahid SM, Nawab SN, Shaikh R, Mahboob T.
    Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
    [Abstract] [Full Text] [Related]

  • 32. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM.
    Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS.
    Diabetes Care; 1995 Jul; 18(7):1013-6. PubMed ID: 7555533
    [Abstract] [Full Text] [Related]

  • 33. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals.
    Temelkova-Kurktschiev T, Koehler C, Schaper F, Henkel E, Hahnefeld A, Fuecker K, Siegert G, Hanefeld M.
    Diabetologia; 1998 Jun; 41(6):706-12. PubMed ID: 9662054
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of serum adiponectin levels in diabetic nephropathy.
    Alnaggar ARLR, Sayed M, El-Deena KE, Gomaa M, Hamed Y.
    Diabetes Metab Syndr; 2019 Jun; 13(1):128-131. PubMed ID: 30641684
    [Abstract] [Full Text] [Related]

  • 35. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
    Imano E, Kanda T, Nakatani Y, Nishida T, Arai K, Motomura M, Kajimoto Y, Yamasaki Y, Hori M.
    Diabetes Care; 1998 Dec; 21(12):2135-9. PubMed ID: 9839106
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M, Cogni G, Sacchi L, Dagliati A, Marini S, Tibollo V, De Cata P, Bellazzi R, Chiovato L.
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.